ATE495252T1 - Neuartige phagenanzeigetechnologien - Google Patents

Neuartige phagenanzeigetechnologien

Info

Publication number
ATE495252T1
ATE495252T1 AT06795080T AT06795080T ATE495252T1 AT E495252 T1 ATE495252 T1 AT E495252T1 AT 06795080 T AT06795080 T AT 06795080T AT 06795080 T AT06795080 T AT 06795080T AT E495252 T1 ATE495252 T1 AT E495252T1
Authority
AT
Austria
Prior art keywords
phage
phage display
display technologies
novel phage
protein
Prior art date
Application number
AT06795080T
Other languages
English (en)
Inventor
Roberto Burioni
Massimo Clementi
Original Assignee
Ribovax Biotechnologies Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribovax Biotechnologies Sa filed Critical Ribovax Biotechnologies Sa
Application granted granted Critical
Publication of ATE495252T1 publication Critical patent/ATE495252T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Liquid Crystal Substances (AREA)
AT06795080T 2005-07-07 2006-07-06 Neuartige phagenanzeigetechnologien ATE495252T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2005007325 2005-07-07
PCT/IB2006/001878 WO2007007154A2 (en) 2005-07-07 2006-07-06 Novel phage display technologies

Publications (1)

Publication Number Publication Date
ATE495252T1 true ATE495252T1 (de) 2011-01-15

Family

ID=37547018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06795080T ATE495252T1 (de) 2005-07-07 2006-07-06 Neuartige phagenanzeigetechnologien

Country Status (14)

Country Link
US (1) US7811973B2 (de)
EP (1) EP1904634B1 (de)
JP (1) JP2009500030A (de)
KR (1) KR20080039869A (de)
CN (1) CN101258243A (de)
AT (1) ATE495252T1 (de)
AU (1) AU2006267968B2 (de)
BR (1) BRPI0612589A2 (de)
CA (1) CA2614304A1 (de)
DE (1) DE602006019598D1 (de)
IL (1) IL188554A0 (de)
RU (1) RU2008104610A (de)
WO (1) WO2007007154A2 (de)
ZA (1) ZA200800104B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2412249C2 (ru) * 2005-07-08 2011-02-20 Юниверсити Оф Цюрих Фаговый дисплей с применением котрансляционной транслокации слитых полипептидов
KR101123641B1 (ko) * 2008-12-31 2012-03-20 키스트 유럽 에프게엠베하 검출 물질에 특이적으로 반응할 수 있는 분자 인지 물질이 진열된 박테리오파아지의 제조 방법 및 상기 제조 방법으로제조된 박테리오파아지를 미량 검출물을 검출하는데 활용하는 방법 및 상기 박테리오파아지를 이용한 질량 분석장치
EP2210944A1 (de) * 2009-01-22 2010-07-28 ATG:biosynthetics GmbH Verfahren zur Erzeugung von RNA- und (Poly)Peptid-Bibliotheken und ihre Verwendung
WO2011074941A1 (en) * 2009-12-15 2011-06-23 Universiti Malaya A method of high throughput screening of inhibitors that inhibit interaction of an attachment protein to cell receptors using recombinant phage display
WO2013115425A1 (en) * 2012-01-31 2013-08-08 Scripps Korea Antibody Institute Methods for screening an antibody by one-cycle panning
EP2825557B1 (de) 2012-03-16 2017-06-28 The U.S.A. as represented by the Secretary, Department of Health and Human Services Manipuliertes lösliches monomeres fc
CN105247050B (zh) * 2013-03-14 2020-06-16 天演药业 用于文库构建、亲和力结合剂筛选和其表达的整合系统
US9493764B2 (en) 2014-04-22 2016-11-15 Korea Institute Of Science And Technology Hybrid electronic sheets
US9226403B2 (en) * 2014-04-22 2015-12-29 Korea Institute Of Science And Technology Hybrid electronic sheets
CN105219780B (zh) * 2015-10-30 2020-06-02 中国人民解放军第三军医大学第一附属医院 抗多亚基因型hcv抗体基因r3-19及其应用
CN105177017B (zh) * 2015-10-30 2020-06-02 中国人民解放军第三军医大学第一附属医院 抗多亚基因型hcv抗体基因r4-85及其应用
CA3018365A1 (en) 2016-03-23 2017-09-28 The General Hospital Corporation Assays and methods for detecting udp-glucose
EP3562953A1 (de) 2016-12-30 2019-11-06 Quidel Corporation Phagen-vermittelter immunoassay und verfahren zur bestimmung der empfindlichkeit von bakterien gegen antibiotika oder probiotika
KR101937883B1 (ko) * 2017-04-04 2019-01-14 한국과학기술연구원 바이오 물질을 포함하는 바인더 조성물
WO2019070612A1 (en) 2017-10-02 2019-04-11 Quidel Corporation PHAGE-BASED DETECTION METHOD FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING AND IDENTIFICATION OF BACTERIAL SPECIES
EP3774926A1 (de) * 2018-04-05 2021-02-17 Bio-Rad ABD Serotec GmbH Anzeigesysteme für proteine von interesse
CN111798712B (zh) * 2020-07-15 2021-10-29 周晓庆 噬菌体侵染细菌3d智能模拟方法
CN115109794A (zh) * 2022-06-30 2022-09-27 武汉生之源生物科技股份有限公司 一种噬菌粒载体及其制备方法和应用
CN116642877B (zh) * 2023-06-01 2025-01-03 深圳市康百得生物科技有限公司 一种噬菌体生物发光阵列细菌检测芯片及其制备方法和应用
CN119144569A (zh) * 2024-11-20 2024-12-17 浙江大学 一种双展示噬菌体及其构建方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002081635A2 (en) * 2001-04-05 2002-10-17 Ramot At Tel Aviv University Phage display vector, phages encoded thereby, and methods of use thereof
EP1373527A1 (de) * 2001-04-06 2004-01-02 CropDesign N.V. Die verwendung doppelter und gegensätzlicher rekombinations-seiten für die 'single-step' klonierung zweier dna segmente
WO2003072773A1 (fr) * 2002-02-08 2003-09-04 Seikagaku Corporation Proteine fusionnee ayant une activite de glucuronyltransferase

Also Published As

Publication number Publication date
JP2009500030A (ja) 2009-01-08
RU2008104610A (ru) 2009-08-20
WO2007007154A3 (en) 2007-04-05
US7811973B2 (en) 2010-10-12
CN101258243A (zh) 2008-09-03
CA2614304A1 (en) 2007-01-18
IL188554A0 (en) 2008-04-13
BRPI0612589A2 (pt) 2010-11-23
WO2007007154A2 (en) 2007-01-18
EP1904634A2 (de) 2008-04-02
DE602006019598D1 (de) 2011-02-24
KR20080039869A (ko) 2008-05-07
AU2006267968A1 (en) 2007-01-18
ZA200800104B (en) 2009-08-26
US20080312101A1 (en) 2008-12-18
AU2006267968B2 (en) 2010-07-29
EP1904634B1 (de) 2011-01-12

Similar Documents

Publication Publication Date Title
IL188554A0 (en) Novel phage display technologies
Durani Protein design with L-and D-α-amino acid structures as the alphabet
EA201100669A1 (ru) Биспецифичные молекулы, связывающие egfr/igfir
CO6280541A2 (es) Anticuerpos monoclonales o fragmentos del mismo que se unen al recptor humano ox40
IL191852A (en) Antibodies directed to her-3 and uses thereof
SG145725A1 (en) Anti-vegf antibodies
EA201792442A1 (ru) Биспецифические агенты, связывающие простатический специфический мембранный антиген (psma), и их применение
WO2007133835A8 (en) Ras mutation and compositions and methods related thereto
JP2015519344A5 (de)
AR038568A1 (es) Anticuerpos anti-a beta y su uso
DE60335000D1 (de) In vitro peptid-expressionsbank
UA92154C2 (ru) Rage-слитые белки и способы их применения
Sugiyama et al. Spatial arrangement and functional role of α subunits of proteasome activator PA28 in hetero-oligomeric form
ATE306498T1 (de) Von zellen präsentierte peptide
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
JP2011004734A5 (de)
WO2012126118A8 (en) Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
EA202091713A1 (ru) Биологический синтез аминокислотных цепей для получения пептидов и белков
Cusano et al. Integration of binding peptide selection and multifunctional particles as tool-box for capture of soluble proteins in serum
Mandrika et al. Proteochemometric modelling of antibody–antigen interactions using SPOT synthesised peptide arrays
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
ATE452994T1 (de) In situ protein mikroarray zusammenbau
JP7095899B2 (ja) 結合部位を決定するための方法およびキット
EP1929015A4 (de) Doppelt fluoreszierendes reporterkonstrukt und test zur messung translationaler rückcodierung
Moore Peptide Affinity Ligands for the Purification of Labile Biologics

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties